CN105126042A - Medicine composition for treating osteoporosis - Google Patents
Medicine composition for treating osteoporosis Download PDFInfo
- Publication number
- CN105126042A CN105126042A CN201510693536.0A CN201510693536A CN105126042A CN 105126042 A CN105126042 A CN 105126042A CN 201510693536 A CN201510693536 A CN 201510693536A CN 105126042 A CN105126042 A CN 105126042A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- radix rehmanniae
- osteoporosis
- achyranthis bidentatae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to the technical field of osteoporosis treatment, in particular to a medicine composition for treating osteoporosis. The medicine composition is prepared from, by weight, 8-15 parts of radix rehmanniae, 8-15 parts of rehmannia glutinosa, 18-23 parts of epimedium herbs, 8-10 parts of fructus psoraleae, 8-10 parts of dipsacus asperoides, 10-15 parts of radix achyranthis bidentatae, 10-15 parts of rhizoma drynariae, 8-15 parts of sweet cistanche, 28-35 parts of raw oysters, 8-13 parts of prepared eupolyphaga sinensis walker and 8-12 parts of zedoary. Compared with the prior art, the medicine composition has the advantages that the radix rehmanniae, the rehmannia glutinosa, the epimedium herbs and the sweet cistanche can invigorate the kidney, replenish essence, and regulate Yin and Yang; the fructus psoraleae, the rhizoma drynariae, the dipsacus asperoides and the radix achyranthis bidentatae can tonify the kidneys, and strengthen the bone and the tendon; the prepared eupolyphaga sinensis walker and the zedoary can activate blood circulation and remove stasis; the raw oysters can reinforce the kidneys and strengthen the bone, and therefore the composition can treat the osteoporosis of kidney deficiency collateral stasis.
Description
Technical field
The present invention relates to the technical field for the treatment of osteoporosis, particularly a kind of pharmaceutical composition for the treatment of osteoporosis.
Background technology
Osteoporosis is one group of osteopathia that many reasons causes, and osseous tissue has normal calcification, and calcium salt and substrate are normal rates, and the metabolic osteopathy being reduced to feature with unit volume inner bone tissues amount becomes.In most osteoporosis, caused by the minimizing of osseous tissue increases mainly due to bone absorption.The traditional Chinese medical science is thought: osteoporosis for the osteoporosis of the network stasis of blood of suffering from a deficiency of the kidney, this symptom be lumbar and back pain, very then bow-backed, or easily fracture, or talalgia, the soft limb fiber crops of knee joint, spasm of muscles and vessels, dizzy weak, thin lingual fur, thready and stringy pulse etc.
In view of this, the applicant furthers investigate the suffer from a deficiency of the kidney technology of osteoporosis of the network stasis of blood of existing treatment, then produces in this case.
Summary of the invention
The object of the invention is to the symptom of the osteoporosis for the existing network stasis of blood of suffering from a deficiency of the kidney, a kind of pharmaceutical composition for the treatment of osteoporosis is provided.
For achieving the above object, the technical solution used in the present invention is:
A kind of pharmaceutical composition for the treatment of osteoporosis of the present invention, described pharmaceutical composition is made up of each component of following weight proportioning,
8 ~ 15 parts, the Radix Rehmanniae, 8 ~ 15 parts, Radix Rehmanniae Preparata, Herba Epimedii 18 ~ 23 parts,
Fructus Psoraleae 8 ~ 10 parts, Radix Dipsaci 8 ~ 10 parts, Radix Achyranthis Bidentatae 10 ~ 15 parts,
Rhizoma Drynariae 10 ~ 15 parts, HERBA CISTANCHES 8 ~ 15 parts, Concha Ostreae 28 ~ 35 parts,
Moxibustion Eupolyphaga Seu Steleophaga 8 ~ 13 parts, Rhizoma Curcumae 8 ~ 12 parts.
Further, described pharmaceutical composition is made up of each component of following weight proportioning, 8 parts, the Radix Rehmanniae, 8 parts, Radix Rehmanniae Preparata, Herba Epimedii 18 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 8 parts, Radix Achyranthis Bidentatae 15 parts, Rhizoma Drynariae 12 parts, HERBA CISTANCHES 10 parts, Concha Ostreae 30 parts, moxibustion Eupolyphaga Seu Steleophaga 8 parts, Rhizoma Curcumae 8 parts, every part of 1g.
Further, described pharmaceutical composition is made up of each component of following weight proportioning, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, Herba Epimedii 20 parts, Fructus Psoraleae 8 parts, Radix Dipsaci 9 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Drynariae 10 parts, HERBA CISTANCHES 8 parts, Concha Ostreae 28 parts, moxibustion Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Curcumae 10 parts, every part of 1g.
Further, described pharmaceutical composition is made up of each component of following weight proportioning, 15 parts, the Radix Rehmanniae, 15 parts, Radix Rehmanniae Preparata, Herba Epimedii 23 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 10 parts, Radix Achyranthis Bidentatae 13 parts, Rhizoma Drynariae 15 parts, HERBA CISTANCHES 15 parts, Concha Ostreae 35 parts, moxibustion Eupolyphaga Seu Steleophaga 13 parts, Rhizoma Curcumae 12 parts, every part of 1g.
The present invention's beneficial effect is compared with prior art: the raw marrow of kidney governing bones store essential substances, if kidney essense loss, channels loses and fills, then the withered senile appearance of bone, and the atrophic debility of bones need not; And the Radix Rehmanniae, Radix Rehmanniae Preparata, Herba Epimedii, HERBA CISTANCHES energy kidney tonifying, essence replenishing in prescription of the present invention, two regulate yin-yang; Fructus Psoraleae, Rhizoma Drynariae, Radix Dipsaci, the strong waist of Radix Achyranthis Bidentatae energy kidney tonifying, the strong muscle of bone strengthening; Moxibustion Eupolyphaga Seu Steleophaga, Rhizoma Curcumae energy blood circulation and removing stasis; Concha Ostreae reinforces the kidney bone strengthening; The osteoporosis of the network stasis of blood therefore, it is possible to treatment is suffered from a deficiency of the kidney.
Detailed description of the invention
Describe the present invention below in conjunction with specific embodiment, following embodiment and explanation are only used for explaining the present invention, but not as a limitation of the invention.
Embodiment 1:
Be equipped with the pharmaceutical composition that the present invention treats osteoporosis, be made up of each component of following weight proportioning, described pharmaceutical composition is made up of each component of following weight proportioning, 8 parts, the Radix Rehmanniae, 8 parts, Radix Rehmanniae Preparata, Herba Epimedii 18 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 8 parts, Radix Achyranthis Bidentatae 15 parts, Rhizoma Drynariae 12 parts, HERBA CISTANCHES 10 parts, Concha Ostreae 30 parts, moxibustion Eupolyphaga Seu Steleophaga 8 parts, Rhizoma Curcumae 8 parts, every part of 1g.
Embodiment 2:
Be equipped with the pharmaceutical composition that the present invention treats osteoporosis, be made up of each component of following weight proportioning, described pharmaceutical composition is made up of each component of following weight proportioning, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, Herba Epimedii 20 parts, Fructus Psoraleae 8 parts, Radix Dipsaci 9 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Drynariae 10 parts, HERBA CISTANCHES 8 parts, Concha Ostreae 28 parts, moxibustion Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Curcumae 10 parts, every part of 1g.
Embodiment 3:
Be equipped with the pharmaceutical composition that the present invention treats osteoporosis, be made up of each component of following weight proportioning, described pharmaceutical composition is made up of each component of following weight proportioning, 15 parts, the Radix Rehmanniae, 15 parts, Radix Rehmanniae Preparata, Herba Epimedii 23 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 10 parts, Radix Achyranthis Bidentatae 13 parts, Rhizoma Drynariae 15 parts, HERBA CISTANCHES 15 parts, Concha Ostreae 35 parts, moxibustion Eupolyphaga Seu Steleophaga 13 parts, Rhizoma Curcumae 12 parts, every part of 1g.
Instructions of taking: above-mentioned prescription drugs water is decocted twice respectively, takes after the mixing of twice medicinal liquid at twice, early after the meal within 30 minutes, take once, sleep evening and take once for first 30 minutes.
Treatment case:
CHENNU scholar, 68 years old, previously aching pain in waist and back more than 4 years, lost article found of bending over before January, slightly firmly then lumbago as folding.Changed in compression sample by x-ray film making display the 1st lumbar vertebra, osteoporosis.Current bed is rested, and stand up or cough etc. is slightly shaken and namely felt lumbago, and lower limb are had a cramp, and thin lingual fur, matter is partially red, thready and stringy pulse.Chinese medical discrimination is deficiency of kidney essence, and channels is retarded by silt, and controls suitable enriching kidney essence, disperse blood stasis and dredge collateral; Take the prescription in example 1, after taking 30 doses, can out-of-bed activity, without obviously shaking pain.Only sitting is slightly of a specified duration, aching pain in waist and back, weakness of the lower extremities, and x-ray film making display the 1st lumbar vertebra is that wedge shape changes.Continue to adopt the prescription in example 1 to take 1 year, aching pain in waist and back, lower limb convulsion is recovered.
The present invention's beneficial effect is compared with prior art: the Radix Rehmanniae, Radix Rehmanniae Preparata, Herba Epimedii, HERBA CISTANCHES energy kidney tonifying, essence replenishing in prescription of the present invention, two regulate yin-yang; Fructus Psoraleae, Rhizoma Drynariae, Radix Dipsaci, the strong waist of Radix Achyranthis Bidentatae energy kidney tonifying, the strong muscle of bone strengthening; Moxibustion Eupolyphaga Seu Steleophaga, Rhizoma Curcumae energy blood circulation and removing stasis; Concha Ostreae reinforces the kidney bone strengthening; The osteoporosis of the network stasis of blood therefore, it is possible to treatment is suffered from a deficiency of the kidney.
The above is only in order to conveniently to illustrate the present invention, and in the scope not departing from the present invention's creation, the various simple covert and modification that the those skilled in the art being familiar with this technology does should belong to protection scope of the present invention.
Claims (4)
1. treat a pharmaceutical composition for osteoporosis, it is characterized in that: described pharmaceutical composition is made up of each component of following weight proportioning,
8 ~ 15 parts, the Radix Rehmanniae, 8 ~ 15 parts, Radix Rehmanniae Preparata, Herba Epimedii 18 ~ 23 parts,
Fructus Psoraleae 8 ~ 10 parts, Radix Dipsaci 8 ~ 10 parts, Radix Achyranthis Bidentatae 10 ~ 15 parts,
Rhizoma Drynariae 10 ~ 15 parts, HERBA CISTANCHES 8 ~ 15 parts, Concha Ostreae 28 ~ 35 parts,
Moxibustion Eupolyphaga Seu Steleophaga 8 ~ 13 parts, Rhizoma Curcumae 8 ~ 12 parts.
2. a kind of medicine group for the treatment of osteoporosis according to claim 1, is characterized in that: described pharmaceutical composition is made up of each component of following weight proportioning, 8 parts, the Radix Rehmanniae, 8 parts, Radix Rehmanniae Preparata, Herba Epimedii 18 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 8 parts, Radix Achyranthis Bidentatae 15 parts, Rhizoma Drynariae 12 parts, HERBA CISTANCHES 10 parts, Concha Ostreae 30 parts, moxibustion Eupolyphaga Seu Steleophaga 8 parts, Rhizoma Curcumae 8 parts, every part of 1g.
3. a kind of medicine group for the treatment of osteoporosis according to claim 1, is characterized in that: described pharmaceutical composition is made up of each component of following weight proportioning, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, Herba Epimedii 20 parts, Fructus Psoraleae 8 parts, Radix Dipsaci 9 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Drynariae 10 parts, HERBA CISTANCHES 8 parts, Concha Ostreae 28 parts, moxibustion Eupolyphaga Seu Steleophaga 10 parts, Rhizoma Curcumae 10 parts, every part of 1g.
4. a kind of medicine group for the treatment of osteoporosis according to claim 1, is characterized in that: described pharmaceutical composition is made up of each component of following weight proportioning, 15 parts, the Radix Rehmanniae, 15 parts, Radix Rehmanniae Preparata, Herba Epimedii 23 parts, Fructus Psoraleae 10 parts, Radix Dipsaci 10 parts, Radix Achyranthis Bidentatae 13 parts, Rhizoma Drynariae 15 parts, HERBA CISTANCHES 15 parts, Concha Ostreae 35 parts, moxibustion Eupolyphaga Seu Steleophaga 13 parts, Rhizoma Curcumae 12 parts, every part of 1g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510693536.0A CN105126042A (en) | 2015-10-24 | 2015-10-24 | Medicine composition for treating osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510693536.0A CN105126042A (en) | 2015-10-24 | 2015-10-24 | Medicine composition for treating osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105126042A true CN105126042A (en) | 2015-12-09 |
Family
ID=54711853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510693536.0A Pending CN105126042A (en) | 2015-10-24 | 2015-10-24 | Medicine composition for treating osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105126042A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641188A (en) * | 2016-01-08 | 2016-06-08 | 浙江中医药大学附属第三医院 | Bone-tonifying oral solution, bone-tonifying compound monomer and medical application of oral solution |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247486A (en) * | 2011-08-04 | 2011-11-23 | 长春市南关区中医院 | Bone health care marrow filling capsule |
-
2015
- 2015-10-24 CN CN201510693536.0A patent/CN105126042A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102247486A (en) * | 2011-08-04 | 2011-11-23 | 长春市南关区中医院 | Bone health care marrow filling capsule |
Non-Patent Citations (3)
| Title |
|---|
| 刘传统，祁红: "骨康颗粒质量标准研究", 《中国药师》 * |
| 刘道清著: "《中药别名大辞典》", 31 January 2013 * |
| 张问渠，张昱主编: "《老年病中医治疗学》", 31 August 2000 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641188A (en) * | 2016-01-08 | 2016-06-08 | 浙江中医药大学附属第三医院 | Bone-tonifying oral solution, bone-tonifying compound monomer and medical application of oral solution |
| CN105641188B (en) * | 2016-01-08 | 2019-10-08 | 浙江中医药大学附属第三医院 | Beneficial bone oral solution, the beneficial compound monomer of bone and the medical applications of oral solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423761C (en) | Chinese medicinal preparation for treating fracture, traumatic injury | |
| CN101607015A (en) | A kind of Chinese medicine composition for the treatment of ischemic necrosis of femoral head | |
| CN103316192B (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103800489A (en) | Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine | |
| CN105343442A (en) | External medicament for treating lubar intervertebral disc protrusion and preparation method thereof | |
| CN105126042A (en) | Medicine composition for treating osteoporosis | |
| CN100542583C (en) | A kind of pharmaceutical composition for the treatment of vertebra and arthropathy | |
| CN105617198A (en) | Method for preparing medicinal liquor for treating wind-cold low back pain | |
| CN105079302A (en) | Medicine for treating wind-cold-dampness arthralgia and meridian and collateral obstruction type cervical spondylosis | |
| CN106138468A (en) | For treating the medicine of cervical spondylosis | |
| CN102100759A (en) | Traditional Chinese medicine composition with functions of tonifying liver and kidney and treating hyperosteogeny | |
| CN104352946A (en) | Chinese patent medicine preparation for treating osteoporosis | |
| CN102366530A (en) | Medicinal liquor for invigorating yang and promoting spermatogenic function | |
| CN102512505B (en) | Chinese patent medicine for treating bone spur | |
| CN106924472A (en) | Cervical vertebra, the lumber ertebral disc rheumatism drug composition taken in a kind of | |
| CN106344793A (en) | Traditional Chinese medicine foot bath powder for treating arthritis and preparation method thereof | |
| CN105998257A (en) | Formula of traditional Chinese medicine for treating lumbar vertebrae bone hyperplasia | |
| CN101584846A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN105079258A (en) | Medicine for treating liver and kidney deficiency and qi and blood deficiency type cervical spondylosis | |
| CN104758504A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN104383366B (en) | A kind of Chinese medicine composition for treating osteoproliferation | |
| CN105596628A (en) | Physiotherapy water with tendon relaxing and blood circulation activating efficacy and preparation method thereof | |
| CN105031535A (en) | Medicinal liquor for treating traumatic injury and preparation method thereof | |
| CN104491001A (en) | Traditional Chinese medicine composition for treating osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151209 |